Standard Biotools (LAB) Change in Receivables (2010 - 2026)

Standard Biotools (LAB) has reported Change in Receivables for 17 consecutive years, with -$1.2 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Change in Receivables fell 552.17% year-over-year to -$1.2 million in Q2 2026; TTM through Jun 2026 was -$326000.0, a 80.34% increase from a year earlier, with the FY2025 full-year figure at $1.4 million, up 115.18% from the prior year.
• Change in Receivables was -$1.2 million for Q2 2026 at Standard Biotools, down from $1.9 million in the prior quarter.
• Over five years, Change in Receivables peaked at $6.2 million in Q3 2022 and troughed at -$6.7 million in Q4 2025.
• A 5-year average of -$281555.6 and a median of $168000.0 in 2022 frame the typical range for Change in Receivables.
• Across the five-year window, Change in Receivables jumped 6013.33% in 2023 and sank 648.29% in 2024, its largest moves.
• Over 5 years, Change in Receivables stood at $60000.0 in 2022, then jumped by 6013.33% to $3.7 million in 2023, then tumbled by 282.52% to -$6.7 million in 2024, then declined by 0.52% to -$6.7 million in 2025, then jumped by 81.46% to -$1.2 million in 2026.
• The last three Change in Receivables figures came in at -$1.2 million (Q2 2026), $1.9 million (Q1 2026), and -$6.7 million (Q4 2025), per Business Quant data.